Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(ε-caprolactone)-poly(ethylene oxide)-poly(ε-caprolactone) amphiphilic triblock copolymer micelles

被引:172
作者
Ge, HX [1 ]
Hu, Y [1 ]
Jiang, XQ [1 ]
Cheng, DM [1 ]
Yuan, YY [1 ]
Bi, H [1 ]
Yang, CZ [1 ]
机构
[1] Nanjing Univ, Coll Chem & Chem Engn, Lab Mesoscop Mat Sci, Nanjing 210093, Peoples R China
关键词
PCL-PEO-PCL block copolymer; micelle; CMC; precipitation method; drug release; nimodipine;
D O I
10.1002/jps.10143
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Amphiphilic triblock copolymers, poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) (PCL-PEO-PCL), were synthesized by ring opening polymerization of epsilon-caprolactone initiated with the hydroxyl functional groups of poly(ethylene glycol) at both ends of the chain. The micelles composed of this type of copolymer had such a structure that both ends of the PEO chain were anchored to the micelle. The critical micelle concentration of the block copolymer in distilled water was determined by a fluorescence probe technique using pyrene. As the hydrophobic components of the block copolymer increased, the critical micelle concentration value decreased. To estimate the feasibility as novel drug carriers, the block copolymer micelles were prepared by precipitation of polymer from acetone solution into water. From the observation of transmission electron microscopy, the micelles exhibited a spherical shape. Nimodipine was incorporated into the hydrophobic inner core of micelles as a lipophilic model drug to investigate the drug release behavior. The PEO/ PCL ratio of copolymer was a main factor in controlling micelle size, drug-loading content, and drug release behavior. As PCL weight ratio increased, the micelle size and drug-loading content increased, and the drug release rate decreased. (C) 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 91:1463-1473, 2002.
引用
收藏
页码:1463 / 1473
页数:11
相关论文
共 34 条
[21]   Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement [J].
Molpeceres, J ;
Guzman, M ;
Aberturas, MR ;
Chacon, M ;
Berges, L .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (02) :206-213
[22]   PREPARATIONS OF BIODEGRADABLE NANOSPHERES OF WATER-SOLUBLE AND INSOLUBLE DRUGS WITH D,L-LACTIDE GLYCOLIDE COPOLYMER BY A NOVEL SPONTANEOUS EMULSIFICATION SOLVENT DIFFUSION METHOD, AND THE DRUG RELEASE BEHAVIOR [J].
NIWA, T ;
TAKEUCHI, H ;
HINO, T ;
KUNOU, N ;
KAWASHIMA, Y .
JOURNAL OF CONTROLLED RELEASE, 1993, 25 (1-2) :89-98
[23]   Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles [J].
Peracchia, MT ;
Vauthier, C ;
Passirani, C ;
Couvreur, P ;
Labarre, D .
LIFE SCIENCES, 1997, 61 (07) :749-761
[24]  
PETRAK K, 1993, DRUGS PHARM SCI, V61, P275
[25]   Synthesis, characterization, and hydrolytic degradation of PLA/PEO/PLA triblock copolymers with short poly(L-lactic acid) chains [J].
Rashkov, I ;
Manolova, N ;
Li, SM ;
Espartero, JL ;
Vert, M .
MACROMOLECULES, 1996, 29 (01) :50-56
[26]   ANTIBODIES AGAINST POLYETHYLENE-GLYCOL PRODUCED IN ANIMALS BY IMMUNIZATION WITH MONOMETHOXY POLYETHYLENE-GLYCOL MODIFIED PROTEINS [J].
RICHTER, AW ;
AKERBLOM, E .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1983, 70 (02) :124-131
[27]  
Shin ILG, 1998, J CONTROL RELEASE, V51, P1
[28]   SURFACE MODIFICATION OF NANOPARTICLES TO OPPOSE UPTAKE BY THE MONONUCLEAR PHAGOCYTE SYSTEM [J].
STORM, G ;
BELLIOT, SO ;
DAEMEN, T ;
LASIC, DD .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 17 (01) :31-48
[29]   SURFACE MODIFICATION OF NANOPARTICLES BY PEO PPO BLOCK-COPOLYMERS TO MINIMIZE INTERACTIONS WITH BLOOD COMPONENTS AND PROLONG BLOOD-CIRCULATION IN RATS [J].
TAN, JS ;
BUTTERFIELD, DE ;
VOYCHECK, CL ;
CALDWELL, KD ;
LI, JT .
BIOMATERIALS, 1993, 14 (11) :823-833
[30]  
Turro N. J., 1980, ANGEW CHEM, V92, P712